Search results
Results from the WOW.Com Content Network
Some manufacturers are recalling some medications containing amlodipine in combination with valsartan or losartan, and some medications containing hydrochlorothiazide HCTZ in combination with...
FDA has updated lists of valsartan products under recall and valsartan products not under recall. Additionally, FDA reminds patients taking this medication or any recalled ARB to continue...
On July 13, 2018, the FDA announced a voluntary recall of some valsartan products because of contamination with NDMA, a potentially cancer-causing chemical. Other drugs affected by the valsartan recall include losartan and irbesartan.
Drug Safety and Availability. Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan. Find out which specific blood pressure medications are...
The U.S. Food and Drug Administration has approved a new generic of the blood pressure medication valsartan to help alleviate a recent shortage due to multiple safety recalls.
On July 13th, the FDA announced a recall of medications containing Valsartan, a generic medication used to treat high blood pressure and heart failure from multiple manufacturers due to an impurity (NDMA) detected in the recalled products.
RemedyRepack recalls several lots of generic valsartan. The FDA releases a testing method to detect NDMA. Manufacturers can use this test to determine if their medications and ingredients are safe for consumers.
Since July 2018, >2 dozen specific ARB products have been recalled owing to the presence of potentially carcinogenic nitrosamine impurities in selected lots. As is the case with all U.S. drug recalls, the ARB recalls have been voluntary on the part of the companies involved.
Several common drugs that contain valsartan, used to treat high blood pressure and heart failure, have been recalled in the United States due to an “impurity” in the drug that poses a potential...
In July 2018, the U.S. Food and Drug Administration announced that three companies had voluntarily recalled several lots of valsartan, which is the generic version of Diovan, because they were contaminated with N-nitrosodimethylamine, or NDMA.